Monica Dinulescu Selected Research

Monica Dinulescu Research Topics

6	Neoplasms (Cancer) 01/2023 - 01/2017
5	Melanoma (Melanoma, Malignant) 01/2023 - 01/2020
2	Merkel Cell Carcinoma 10/2023 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021 - 10/2020
1	Hutchinson's Melanotic Freckle (Lentigo Maligna) 09/2023
1	Dysbiosis 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Skin Diseases (Skin Disease) 02/2017
1	Drug Hypersensitivity Syndrome 09/2012

2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA 01/2021 - 01/2021
2	pembrolizumabIBA 10/2020 - 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 09/2023
1	Proton Pump InhibitorsIBA 01/2023
1	dabrafenibIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	cemiplimabIBA 07/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	AntibodiesIBA 01/2021
1	LigandsIBA 10/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 09/2012